Orforglipron improved weight and metabolic measures, with gastrointestinal side effects
A trial review reported weight loss and changes in blood sugar and lipids, alongside more gastrointestinal problems and treatment discontinuation at some doses.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The pooled trials found that orforglipron reduced body weight and improved blood sugar and lipid measurements compared with placebo in people with obesity. Gastrointestinal side effects and stopping treatment were concerns at some doses. These findings describe weight and laboratory outcomes; they do not establish fewer cardiovascular events or a long-term survival benefit.
This abstract-based summary lacks treatment durations and detailed results by diabetes status. It also does not report direct dose comparisons that would establish which dose offers the best balance of benefits and harms.
What researchers found
Body weight
Orforglipron versus placebo in people with obesity. Treatment duration: Not reported in the abstract.
Which outcomes changed
The review reported reductions in body mass index and waist circumference as well as body weight. Blood sugar and several blood lipid measurements also improved, but these are distinct from direct measurements of cardiovascular events.
How tolerability featured
Gastrointestinal adverse events and treatment discontinuation were more frequent at some doses. Serious adverse events and mortality were reported as similar to placebo, but the abstract does not establish equal safety or long-term outcomes.
The original publication
Efficacy and Safety of Orforglipron in Obese Adults With or Without Diabetes: A Systematic Review and Meta-Analysis.
Pandey RK, Jan M, Mohammad A et al.
Endocrinol Diabetes Metab · 2025
- PubMed ID
- 41296780
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.